4-(5-((3-(2-methoxy-2-oxoethyl)-2,4-dioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid

ID: ALA570525

Chembl Id: CHEMBL570525

PubChem CID: 2176818

Max Phase: Preclinical

Molecular Formula: C18H13NO7S

Molecular Weight: 387.37

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)CN1C(=O)S/C(=C\c2ccc(-c3ccc(C(=O)O)cc3)o2)C1=O

Standard InChI:  InChI=1S/C18H13NO7S/c1-25-15(20)9-19-16(21)14(27-18(19)24)8-12-6-7-13(26-12)10-2-4-11(5-3-10)17(22)23/h2-8H,9H2,1H3,(H,22,23)/b14-8-

Standard InChI Key:  XHMQLKBVYZMWMH-ZSOIEALJSA-N

Associated Targets(Human)

ITGB2 Tclin Integrin alpha-M/beta-2 (32 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 387.37Molecular Weight (Monoisotopic): 387.0413AlogP: 2.85#Rotatable Bonds: 5
Polar Surface Area: 114.12Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 3.90CX Basic pKa: CX LogP: 1.98CX LogD: -1.23
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.62Np Likeness Score: -1.34

References

1. Faridi MH, Maiguel D, Barth CJ, Stoub D, Day R, Schürer S, Gupta V..  (2009)  Identification of novel agonists of the integrin CD11b/CD18.,  19  (24): [PMID:19879752] [10.1016/j.bmcl.2009.10.077]

Source